Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine
Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Subjects with depressive episodes will be recruited to undergo a brief 2 week course of IV
infusions of ketamine in combination with cognitive behavioral therapy for 8 weeks.